loading
Actinium Pharmaceuticals Inc stock is traded at $1.365, with a volume of 210.27K. It is down -0.83% in the last 24 hours and down -13.39% over the past month. Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for patients with cancers lacking effective treatment options. Its lead product candidate is Iomab-B that is in Phase III clinical studies for myeloablation and conditioning of the bone marrow prior to a bone marrow transplant for patients with relapsed or refractory acute myeloid leukemia (AML) age 55 and older. The company is also developing Actimab-A, which is in Phase II clinical trials for the treatment of patients newly diagnosed with AML over the age of 60, as well as in Phase I clinical trials in combination with CLAG-M for patients with relapsed or refractory AML; and Actimab-M that is in Phase I clinical trials for patients with refractory multiple myeloma. Actinium Pharmaceutical, Inc. was founded in 2000 and is based in New York, New York.
See More
Previous Close:
$1.38
Open:
$1.35
24h Volume:
210.27K
Relative Volume:
1.15
Market Cap:
$42.58M
Revenue:
$81,000
Net Income/Loss:
$-41.04M
P/E Ratio:
-1.0365
EPS:
-1.3169
Net Cash Flow:
$-30.69M
1W Performance:
-7.53%
1M Performance:
-13.39%
6M Performance:
-11.71%
1Y Performance:
-22.25%
1-Day Range:
Value
$1.33
$1.40
1-Week Range:
Value
$1.33
$1.48
52-Week Range:
Value
$1.06
$2.41

Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile

Name
Name
Actinium Pharmaceuticals Inc
Name
Phone
646-767-3870
Name
Address
275 Madison Avenue, 7th Floor, New York, NY
Name
Employee
25
Name
Twitter
@actiniumpharma
Name
Next Earnings Date
2025-08-08
Name
Latest SEC Filings
Name
ATNM's Discussions on Twitter

Compare ATNM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ATNM
Actinium Pharmaceuticals Inc
1.365 43.05M 81,000 -41.04M -30.69M -1.3169
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.78 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.49 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
427.43 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
842.67 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
185.44 39.72B 447.02M -1.18B -868.57M -6.1812

Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-07-24 Downgrade B. Riley Securities Buy → Neutral
May-14-24 Initiated Stephens Overweight
Sep-06-23 Initiated HSBC Securities Buy
Feb-21-23 Downgrade William Blair Outperform → Mkt Perform
Sep-08-22 Initiated Cantor Fitzgerald Overweight
Aug-25-22 Initiated B. Riley Securities Buy
Nov-05-20 Initiated Alliance Global Partners Buy
Dec-06-17 Initiated B. Riley FBR, Inc. Buy
Oct-23-17 Resumed ROTH Capital Buy
Sep-14-17 Initiated Maxim Group Buy
Aug-25-16 Initiated ROTH Capital Buy
Feb-29-16 Initiated H.C. Wainwright Buy
Oct-15-15 Initiated FBR Capital Outperform
Oct-01-14 Initiated MLV & Co Buy
Jul-22-14 Initiated Canaccord Genuity Buy
View All

Actinium Pharmaceuticals Inc Stock (ATNM) Latest News

pulisher
08:10 AM

Is Actinium Pharmaceuticals Inc. (7AY1) stock a momentum leaderJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - newser.com

08:10 AM
pulisher
07:30 AM

Actinium Pharmaceuticals, Inc. to Highlight ATNM-400 Data in Hormone-Resistant and HER2-Resistant Breast Cancer at the 2025 San Antonio Breast Cancer Symposium, Expanding Pan-Tumor Profile Across Three Solid Tumor Indications - WV News

07:30 AM
pulisher
06:19 AM

Can you recover from losses in Actinium Pharmaceuticals Inc.Watch List & Technical Buy Zone Confirmation - newser.com

06:19 AM
pulisher
04:15 AM

Identifying reversal signals in Actinium Pharmaceuticals Inc.Weekly Investment Report & Community Trade Idea Sharing - newser.com

04:15 AM
pulisher
03:09 AM

Why retail traders accumulate Actinium Pharmaceuticals Inc. (Delaware) stockJuly 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com

03:09 AM
pulisher
02:31 AM

What momentum shifts mean for Actinium Pharmaceuticals Inc.2025 Top Gainers & Reliable Price Breakout Signals - newser.com

02:31 AM
pulisher
01:33 AM

Will Actinium Pharmaceuticals Inc. (7AY1) stock outperform foreign stocks2025 Bull vs Bear & AI Powered Market Trend Analysis - newser.com

01:33 AM
pulisher
Nov 03, 2025

How Actinium Pharmaceuticals Inc. (Delaware) stock expands through international marketsTrade Signal Summary & Verified Stock Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How moving averages guide Actinium Pharmaceuticals Inc. tradingWeekly Profit Summary & Weekly High Potential Stock Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Actinium Pharmaceuticals Inc. stock ready for a breakoutJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Actinium Pharmaceuticals, Inc. to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference - PR Newswire

Nov 03, 2025
pulisher
Nov 03, 2025

How supply shortages influence Actinium Pharmaceuticals Inc. (Delaware) stockPortfolio Gains Report & Weekly Market Pulse Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Actinium Pharmaceuticals Inc. stock a smart buy before Fed meetingProduct Launch & Fast Entry Momentum Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Actinium Pharmaceuticals Inc. stock performs in rate cut cycles2025 Trade Ideas & Accurate Buy Signal Notifications - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Actinium Pharmaceuticals Inc. stock entering bullish territoryJuly 2025 Closing Moves & Stepwise Trade Execution Plans - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

How Actinium Pharmaceuticals Inc. (Delaware) stock stacks up against competitors2025 Year in Review & Low Risk High Reward Trade Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Has Actinium Pharmaceuticals Inc. found a price floorIndex Update & AI Driven Stock Reports - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Why Actinium Pharmaceuticals Inc. (Delaware) stock stays undervaluedMarket Volume Summary & AI Based Buy and Sell Signals - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

How Actinium Pharmaceuticals Inc. (Delaware) stock responds to bond marketJuly 2025 Volume & Fast Moving Market Watchlists - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will Actinium Pharmaceuticals Inc. (7AY1) stock gain from lower interest ratesQuarterly Market Summary & Community Consensus Trade Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 04:06:04 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Actinium Pharmaceuticals Inc. (Delaware) stock a buy on weaknessWeekly Risk Report & AI Powered Buy and Sell Recommendations - newser.com

Oct 31, 2025

Actinium Pharmaceuticals Inc Stock (ATNM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.96
price up icon 1.68%
$29.20
price up icon 1.74%
$102.08
price up icon 0.58%
$103.42
price down icon 0.49%
biotechnology ONC
$315.32
price up icon 1.14%
$185.65
price down icon 0.42%
Cap:     |  Volume (24h):